These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Vaccinating adolescents and young women against cancer of the cervix. Hilgers RD; Wyatt SW J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465 [No Abstract] [Full Text] [Related]
25. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]. Dillner J; Andrae B; Westermark B Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260 [No Abstract] [Full Text] [Related]
26. [Identification and genotyping of oncogenic type of human papillomavirus in paraffin-embedded cervical cancer samples in Guangzhou]. Zeng L; Yu SY; Gou SQ; Yun JP; Zhang J Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2485-7. PubMed ID: 20034908 [TBL] [Abstract][Full Text] [Related]
27. Screening for cervical cancer: controversy and contention or thoughtful analysis. Frable WJ Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849 [No Abstract] [Full Text] [Related]
28. The quadrivalent human papillomavirus vaccine. Wheat A Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317 [No Abstract] [Full Text] [Related]
29. On viruses, discovery, and recognition. Weiss RA Cell; 2008 Dec; 135(6):983-6. PubMed ID: 19070561 [TBL] [Abstract][Full Text] [Related]
30. Prospects for cervical cancer prevention by human papillomavirus vaccination. Schiller JT; Lowy DR Cancer Res; 2006 Nov; 66(21):10229-32. PubMed ID: 17079437 [TBL] [Abstract][Full Text] [Related]
31. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control]. Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976 [TBL] [Abstract][Full Text] [Related]
32. Who should get the HPV vaccine? Pichichero ME J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808 [No Abstract] [Full Text] [Related]
33. Preface. Gissmann L; García Carrancá A Arch Med Res; 2009 Aug; 40(6):427. PubMed ID: 19853181 [No Abstract] [Full Text] [Related]
34. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE; Unger ER; Saraiya M J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
35. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [TBL] [Abstract][Full Text] [Related]
36. How much cervical cancer in Australia is vaccine preventable? A meta-analysis. Brotherton JM Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276 [TBL] [Abstract][Full Text] [Related]
37. The Nobel prize in physiology or medicine for 2008. Jonsson R Scand J Immunol; 2008 Dec; 68(6):553. PubMed ID: 19055695 [No Abstract] [Full Text] [Related]
38. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Schiffman M Cancer; 2007 Jun; 111(3):145-53. PubMed ID: 17487850 [TBL] [Abstract][Full Text] [Related]
39. [Papillomavirus and cervical carcinoma]. Launay O Med Sci (Paris); 2008 Nov; 24(11):981-2. PubMed ID: 19038104 [No Abstract] [Full Text] [Related]
40. Cervarix--a second HPV vaccine. Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]